Immunoclassification of Psoriasis: a Strategy for Precision Medicine
Conditions:   Immunoclassification;   Psoriasis Intervention:   Biological: adalimumab, secukinumab, ixekizumab, guselkumab, Jak inhibitors, methotrexate Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2022 Category: Research Source Type: clinical trials

Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis
Condition:   Rheumatoid Arthritis Interventions:   Drug: Filgotinib;   Drug: Adalimumab Sponsors:   Leiden University Medical Center;   Galapagos NV Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2022 Category: Research Source Type: clinical trials

To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis
Condition:   Moderate to Severe Chronic Plaque Psoriasis Interventions:   Biological: CT-P17;   Biological: EU-approved Humira Sponsor:   Celltrion Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2022 Category: Research Source Type: clinical trials